Voermann Karsten's most recent trade in GoodRx Holdings Inc - Ordinary Shares - Class A was a trade of 89,292 Class A Common Stock done . Disclosure was reported to the exchange on Jan. 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2025 | 89,292 | 392,596 | - | - | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2025 | 89,292 | 267,876 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.41 per share. | 08 Jan 2025 | 29,035 | 363,561 | - | 4.4 | 128,044 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2024 | 54,064 | 378,448 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2024 | 54,064 | 327,963 | - | - | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.91 per share. | 08 Dec 2024 | 24,659 | 303,304 | - | 4.9 | 121,076 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2024 | 54,064 | 298,599 | - | - | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2024 | 54,064 | 432,512 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.71 per share. | 08 Sep 2024 | 24,700 | 273,899 | - | 7.7 | 190,437 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2024 | 54,064 | 266,016 | - | - | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2024 | 54,064 | 486,576 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.55 per share. | 08 Jun 2024 | 21,481 | 244,535 | - | 8.6 | 183,663 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 515,793 | 515,793 | - | - | Stock Option (Right to Buy) | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 357,168 | 357,168 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 54,064 | 229,192 | - | - | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 54,064 | 540,640 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.54 per share. | 08 Mar 2024 | 17,240 | 211,952 | - | 7.5 | 129,990 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Voermann Karsten | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 54,064 | 594,704 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 54,064 | 199,885 | - | 0 | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.94 per share. | 08 Dec 2023 | 24,757 | 175,128 | - | 5.9 | 147,057 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 54,064 | 702,832 | - | - | Restricted Stock Units | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 54,064 | 128,125 | - | - | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.41 per share. | 08 Jun 2023 | 16,611 | 111,514 | - | 5.4 | 89,866 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 54,064 | 91,458 | - | - | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 54,064 | 756,896 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.50 per share. | 08 Mar 2023 | 17,397 | 74,061 | - | 5.5 | 95,684 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2022 | 54,063 | 54,063 | - | - | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2022 | 54,063 | 810,960 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.98 per share. | 08 Dec 2022 | 16,669 | 37,394 | - | 5.0 | 83,012 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2022 | 865,023 | 865,023 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2021 | 12,500 | 342,500 | - | - | Stock Option (Right to Buy) | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 33.05 per share. | 28 Dec 2021 | 12,500 | 0 | - | 33.1 | 413,183 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.84 per share. | 28 Dec 2021 | 12,500 | 12,500 | - | 6.8 | 85,500 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 12,500 | 355,000 | - | - | Stock Option (Right to Buy) | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.84 per share. | 01 Dec 2021 | 12,500 | 12,500 | - | 6.8 | 85,500 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 40.22 per share. | 01 Dec 2021 | 6,111 | 0 | - | 40.2 | 245,783 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.35 per share. | 01 Dec 2021 | 4,189 | 8,311 | - | 38.3 | 160,646 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.31 per share. | 01 Dec 2021 | 2,200 | 6,111 | - | 39.3 | 86,475 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 12,500 | 367,500 | - | - | Stock Option (Right to Buy) | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.84 per share. | 01 Nov 2021 | 12,500 | 12,500 | - | 6.8 | 85,500 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 44.04 per share. | 01 Nov 2021 | 12,300 | 200 | - | 44.0 | 541,660 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Nov 2021 | 200 | 0 | - | 0 | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Sep 2021 | 7,500 | 380,000 | - | - | Stock Option (Right to Buy) | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.84 per share. | 28 Sep 2021 | 7,500 | 7,500 | - | 6.8 | 51,300 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 40.22 per share. | 28 Sep 2021 | 7,000 | 500 | - | 40.2 | 281,539 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 41.52 per share. | 28 Sep 2021 | 500 | 0 | - | 41.5 | 20,758 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.84 per share. | 30 Aug 2021 | 12,500 | 12,500 | - | 6.8 | 85,500 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2021 | 12,500 | 387,500 | - | - | Stock Option (Right to Buy) | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 37.00 per share. | 30 Aug 2021 | 12,400 | 100 | - | 37.0 | 458,757 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 37.71 per share. | 30 Aug 2021 | 100 | 0 | - | 37.7 | 3,771 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2021 | 12,500 | 400,000 | - | - | Stock Option (Right to Buy) | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.84 per share. | 28 Jul 2021 | 12,500 | 12,500 | - | 6.8 | 85,500 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 32.92 per share. | 28 Jul 2021 | 7,842 | 0 | - | 32.9 | 258,133 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 32.46 per share. | 28 Jul 2021 | 4,658 | 7,842 | - | 32.5 | 151,215 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 37.37 per share. | 28 Jun 2021 | 12,500 | 0 | - | 37.4 | 467,161 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2021 | 12,500 | 412,500 | - | - | Stock Option (Right to Buy) | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.84 per share. | 28 Jun 2021 | 12,500 | 12,500 | - | 6.8 | 85,500 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2021 | 12,500 | 425,000 | - | - | Stock Option (Right to Buy) | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.84 per share. | 28 May 2021 | 12,500 | 12,500 | - | 6.8 | 85,500 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 37.49 per share. | 28 May 2021 | 7,969 | 4,531 | - | 37.5 | 298,794 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.58 per share. | 28 May 2021 | 4,281 | 250 | - | 38.6 | 165,177 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.09 per share. | 28 May 2021 | 250 | 0 | - | 39.1 | 9,773 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2021 | 12,500 | 437,500 | - | - | Stock Option (Right to Buy) | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.84 per share. | 28 Apr 2021 | 12,500 | 12,500 | - | 6.8 | 85,500 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 40.22 per share. | 28 Apr 2021 | 11,999 | 501 | - | 40.2 | 482,584 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 41.05 per share. | 28 Apr 2021 | 501 | 0 | - | 41.1 | 20,568 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.84 per share. | 29 Mar 2021 | 150,000 | 150,000 | - | 6.8 | 1,026,000 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2021 | 150,000 | 450,000 | - | - | Stock Option (Right to Buy) | |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 37.03 per share. | 29 Mar 2021 | 102,431 | 47,569 | - | 37.0 | 3,793,010 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 37.72 per share. | 29 Mar 2021 | 47,469 | 100 | - | 37.7 | 1,790,683 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Karsten Voermann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.54 per share. | 29 Mar 2021 | 100 | 0 | - | 38.5 | 3,854 | Class A Common Stock |